Catalyst Funds Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,900	Closed	-$189K	–	416
2024 Q3	$189K	Sell	24,900 -3,600	-13%	-$27.4K	0.04%	306
2024 Q2	$176K	Buy	+28,500	New	+$176K	0.05%	219